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The incidence of oesophageal cancer in KwaZulu-Natal is high and despite advances in management, it 
remains a disease with dismal outcomes. Most patients in the public health sector present with 
advanced tumours and can only be offered palliation.    
The research project reviewed our current experience with the disease and highlighted long delays in 
presentation and lack of access to appropriate palliative therapies. In light of this we then reviewed our 
processes of care to see if we could improve access to palliative care. 
 One of the strategies identified was to increase access to self-expanding metal stent (SEMS) insertion by 
refining the process of placing these stents.  Once this process had been refined and streamlined we 
audited our experience with it to show that our approach is safe and effective and then we costed it to 
show that it is associated with marked cost savings in comparison to others techniques.   
The first paper in this thesis observed that there were long delays in the diagnosis and management of 
oesophageal cancer.  This study attempted to quantify the delay as well as identify factors behind it. A 
cohort of patients with oesophageal cancer was analysed and a timeline plotted from first symptom, to 
presentation at base hospital, all the way through to definitive management at a tertiary centre. Points 
of delay were defined and reasons behind it were explored. It was postulated that by understanding the 
reasons behind the delay, we could identify points of impact and encourage earlier presentation. Only 
by significantly reducing delays can we hope to impact on the management and long term outcomes of 
this cancer.   
The second paper of this thesis focused on the use of SEMS for palliation of dysphagia in inoperable 
oesophageal cancer in our setting.  In most institutions this procedure is performed under fluoroscopy, a 
resource that is not readily available at our institution. To obviate the delays that this meant for our 
patients, we have been using a direct-vision approach which does not require fluoroscopy.  This paper 
documented our experience with this alternative technique and showed that it is both safe and effective  
It audited our extensive experience with this modified technique at the Gastrointestinal Unit at Greys 
hospital over a period of five years.  We described our pure endoscopic technique and compared our 
experience with other large studies using similar and alternate techniques.  
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The final paper in this thesis describes a cost analysis of both techniques. It goes on to show that the 
pure endoscopic technique is safe and effective and is associated with significant cost savings in 
comparison to the standard fluoroscopy-driven technique performed at another tertiary centre in our 
province. 
It is hoped that by showing that our direct vision technique is safe, effective and cost efficient, we can 
pave the way for this procedure to become the standard practice in a resource constrained health 
system. This would allow the procedure to be performed at many regional centres and not be restricted 
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Chapter 1 : Introduction 
 
Oesophageal cancer is a devastating disease. It is one of the least studied and most lethal cancers 
worldwide and ranks sixth among all cancers globally in terms of mortality1. Despite advances in its 
management, the overall 5-year survival is still low (17%)5.  At the time of presentation, more than 50% 
of patients have metastatic disease, nearly 30% have a tumour that is locally advanced and less than 
20% have an early lesion that can be cured 5 
The burden of oesophageal cancer in South Africa is equally devastating, with the number of cancer-
related deaths second only to cervical cancer.1 In Sub-Saharan Africa, the annual mortality from 
oesophageal cancer is close to the number of new cases diagnosed each year1. 
 In contrast to the situation seen in developed countries, adenocarcinoma of the oesophagus is not 
common in South Africa, and is not often seen in the public health care setting2. 
The subtype of squamous cell carcinoma of the oesophagus is the most prevalent type with an incidence 
of 46.7/100000 for males and 19.2/100000 for females. These figures are for the Eastern Cape 2,3 which 
has traditionally been seen as the epicentre for oesophageal cancer in South Africa. While the exact 
incidence in Gauteng and KwaZulu-Natal are unknown due to lack of official statistics, there seems to be 
a significant number of cases based on hospital reporting4,7.   
The curative management of oesophageal cancer involves complete surgical and/or endoscopic 
resection together with multimodal oncological therapy6. Sadly, most patients in South Africa present 
with locally advanced or metastatic disease amenable only to palliation2,4. In spite of the burden of 
oesophageal cancer in South Africa and its attendant morbidity and mortality, there has been little focus 
on research into this condition locally7. Loots et al published a good historical overview of this disease in 
South Africa and described the current research on the topic as being in a state of crisis. It is hoped that 
this study will address this crisis by developing research themes which will help South African 








The seed for this study was first planted when I arrived as a consultant in the department of surgery at 
Greys hospital in Pietermaritzburg in 2010. I noted at the time that there were a high number of patients 
with oesophageal cancer being palliated with the use of self-expanding metal stents (SEMS). What 
intrigued me was that these were being inserted routinely without the use of fluoroscopy with seeming 
efficacy and safety. While this technique had been described in world literature in resource-constrained 
countries, there was no South African study describing its use and certainly no large-volume centre in 
South Africa routinely utilizing this method. 
At this time, I consulted with the GI subspecialist surgeon at Greys, Mr L Ferndale, to perform a 
departmental audit on this technique. As the sheer number of patients became apparent, we realized 
that this data could be shared through scientific publication and the idea of an MMedSc was conceived 
with supervisors Prof DL Clarke and Prof C Aldous. A formal concept sheet and study protocol was 
developed. Ethics approval was granted through direct application to the Biomedical Research Ethics 
Committee(BREC) at the University of KwaZulu-Natal (UKZN). 
Although the initial concept was to look at the novel stent deployment technique and its effectiveness, it 
soon emerged that there were other research questions that could be answered. It was noted that most 
patients presented late with advanced disease and that there seemed to be delays in the diagnosis and 
management of oesophageal cancer in general in the Pietermaritzburg drainage area. Although this 
delay was “common knowledge” within the medical fraternity involved, it seemed prudent to delve 
deeper into this dilemma and obtain information that was more than just anecdotal. Investigation and 












Pietermaritzburg is the capital city of KwaZulu-Natal and is the largest city in the western part of the 
province which is also known as Area 2 as per the Department of Health designation.  
 
Figure 1 : MAP OF HEALTH DISTRICTS IN KWAZULU NATAL 
Area 2 is a predominantly rural community comprising 4 health districts and servicing a patient 
population of approximately 2 million. Greys hospital is the only tertiary level hospital servicing this 
area. As such it is the only centre in Area 2 to practice advanced interventional endoscopy techniques 
(like stent insertion) and provides the only Oncology service to Area 2 as well. 
The bulk of the data collection for this MMed Sci was obtained from Greys hospital. 
 The following aspects of the thesis were confined to Greys hospital : 
 Retrospective chart audit for the stent technique and efficacy arm 




In the comparative arm of this study (ie. fluoroscopy versus stenting under direct vision only), Inkosi 
Albert Luthuli Central Hospital (IALCH) in Durban formed the setting for the fluoroscopic arm of the 
study. IALCH is a large specialized centre and the only quarternary hospital in KwaZulu-Natal. The GI unit 
there has ready access to fluoroscopy and thus routinely performs stent insertion under fluoroscopy. It 
thus provided the perfect setting for comparison between the two techniques. 
 
Study aims 
The aims of this research project were : 
 To provide an overview on oesophageal cancer in Area 2, and highlight the need for timely and 
effective palliation  
 To quantify the timeline from symptoms to diagnosis and management, with specific emphasis 
on delays 
 To provide a detailed description of an alternative technique of stent placement for palliation 
which utilizes only endoscopy as opposed to routine usage of fluoroscopy 
 To assess safety and efficacy of this technique by retrospectively reviewing  its usage over a five 
year period 
 To compare the cost effectiveness of using a pure endoscopic technique versus traditional 
routine fluoroscopy to insert SEMS 
Structure of the thesis 
This is a thesis by publication and consists of three parts. Each part corresponds to a paper which is 
either published or currently under review. 
 Chapter two introduces us to the problem of oesophageal cancer in South Africa. It sets the 
background for the sheer magnitude of the problem and provides an overview of the timeline 
from first symptom to definitive management, with specific focus on the delays encountered. It 
also attempts to objectively define reasons behind these delays. 
 Chapter three reviews the use of SEMS for palliation of dysphagia in oesophageal cancer with 
specific emphasis on the technique sans fluoroscopy which is used at Greys hospital. This purely 
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endoscopic technique was borne out of an institutional need and this section details the 
technique and provides a five-year review of the peri-procedural outcome.9, 10, 11, 12 
 Chapter four compares the pure endoscopic technique (used at Greys hospital, 
Pietermaritzburg) with the standard fluoroscopic technique used at IALCH, Durban. It analyses 
differences and provides a comparison of cost, time and radiation exposure between the two 
techniques. It further examines the financial implications in a resource-constrained environment 
with a high burden of disease taking example from a local costing study.8 
 The final chapter includes conclusions and recommendations and provides a summary of the 
thesis. It suggests future developments to improve the management of oesophageal cancer and 
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Chapter 2 : Oesophageal Cancer in South Africa : An introduction to the burden 
of disease and analysis of deficiencies in management 
Chapter two introduces us to the sheer magnitude of oesophageal cancer in rural South Africa. It 
highlights that most patients present with advanced disease and emphasises the need for timely and 
effective palliation. This paper also underscores deficiencies within the health care system, pre-hospital 
and in-hospital with specific focus on delays in seeking medical attention, and delays in timely diagnosis 
and management of oesophageal cancer. 
It is hoped that by defining these barriers to timely presentation and management, quality improvement 





Oesophageal cancer in South Africa: The shocking timeline from onset of symptoms to definitive 
management.  Govender M, Ferndale L, Clarke DL                                                                              
(Submitted and currently under review with SA Family Practice Journal) 
 
Abstract 
Background   
In rural South Africa most patients with oesophageal cancer have delayed presentations with 
debilitating symptoms and inoperable disease. This study was undertaken to quantify the delay between 
onset of symptoms and definitive treatment in rural South Africa. It also sought to establish reasons for 
delays in seeking medical attention and identify ways to encourage earlier presentation. 
Patients and Methods:  
It was a two-armed study of patients with oesophageal cancer seen at Greys Hospital in 
Pietermaritzburg. One was a retrospective chart review establishing a timeline. The second part was a 
prospective study between June and November 2012 where data was collected by means of patient 
interviews. 
Results: 
One hundred and thirteen charts were reviewed.  The timelines from first symptoms to definitive 
management was two to 14 months (average seven months). Forty-six patients were interviewed. All 
experienced dysphagia but 83 % were only prompted to seek help after weight loss. The duration of 
symptoms prior to first clinic/hospital attendance was 0 – 12 months (average three months).  The 
reasons for the delay included the following: 41 % of patients didn’t consider dysphagia a significant 
symptom, 24 % had no money, 19 % sought the help of traditional healers first, 15% said the hospital 
was too far away. 
Conclusion:  
There are long delays in the management of oesophageal cancer in our setting. The delays are 
prehospital as well as within the healthcare system. Targeted quality improvement interventions are 
necessary. The most significant reasons patients defer seeking medical attention are lack of knowledge 
about oesophageal cancer symptoms and limited access to healthcare. Patient education and improved 







There is evidence to suggest that the referral system for acute surgical illness in South Africa is 
inefficient and this translates into poor outcomes for diseases such as acute appendicitis1. There has not 
been much research done on the situation with regards surgical oncology.  Oesophageal cancer in South 
Africa is the commonest malignancy in African males and the prognosis remain dismal2-5. Most patients 
present late with inoperable disease and therapeutic interventions are directed at palliation rather than 
at cure.  The objective of this study was to quantify the delay between the onset of symptoms and 
definitive treatment in our environment and to identify the reasons behind these delays. This study 
attempts to provide a timeline from the onset of symptoms of oesophageal cancer through to definitive 
care.   
 Patients and Methods 
This study was conducted at Greys Hospital in Pietermaritzburg in 2012. It was a two-pronged study and 
both quantitative and qualitative methodologies were used. The first arm was a retrospective chart 
review of all patients with oesophageal cancer diagnosed between January and November 2012. 
Patients were identified from combined records of the Oncology clinic, the Surgical outpatients 
department (SOPD) and the Gastrointestinal Unit. These charts were then retrieved and analysed and a 
timeline plotted. This documented the time elapsed between onset of symptoms, presentation at a 
health facility, time to diagnosis and to definitive/palliative care. The overall timeline from first symptom 
to definitive care was also plotted, and overall standardisation of management for oesophageal cancer 
in these patients was also assessed. 
The second aspect was a detailed qualitative interview of patients with oesophageal cancer to assess 
their experience with the health system during the management of their tumour. This was undertaken 
between June – November 2012 and consisted of 46 consecutive patients seen with oesophageal cancer 
at the SOPD during this time period. A single interviewer was used to eliminate bias. Each interview 
followed a standard format that sought detailed information on the onset of symptoms and the time to 
the first presentation to hospital. Specific questions were also asked to understand what prompted 






Prospective qualitative assessment  
Forty-six consecutive patients with oesophageal cancer who were treated at Greys Hospital, 
Pietermaritzburg between June and November 2012 were interviewed by the primary author. The 
commonest symptoms were dysphagia (100%), loss of weight (91 %), weakness (50%) and abdominal 
pain (13%).  The symptoms that prompted presentation were weight loss (83 %) and dysphagia (17%). 
This group experienced symptoms for an average of three months (range 1 -12 months) before seeking 
attention. The following reasons were given for not seeking help earlier: lack of funds (24%), need to 
seek traditional advice first (19%), distance to health care facility (15%).  Forty-one percent did not 
consider dysphagia to be a significant problem. 
 
Chart review 
A total of 113 charts were, reviewed from January to December 2012.  Of the 113 patients, 25 % had 
been referred primarily to Oncology and 75% to surgical outpatients.  A total of three underwent 
resectional surgery, six underwent radiotherapy and one hundred received a self-expanding metal stent 
for palliation. The average time from onset of symptoms to presentation was five months, from 
presentation to diagnosis two months, from diagnosis to definitive management one month. The 





Table 1 : Timeline of delay 
 
 
 RANGE AVERAGE 
First symptoms 0 – 12 months 5 months 
Time to diagnose 0 – 8 months 2 months 
Definitive Mx 0 – 7 months 1 month 




Table 2 summarizes the delays from presentation to the various investigations obtained and emphasizes 
the non-standardised care ie. Not every patient was investigated fully. 
 









There is a growing body of work looking at inequalities in outcome of surgical diseases and there is good 
evidence that economic status determines both health seeking behavior and clinical outcome.  This has 
been clearly demonstrated in acute surgical conditions in South Africa.1 The situation with surgical 
oncology is under-reported on but there is evidence to suggest that rural African patients with 
malignancy present late and have more advanced disease than other groups with similar disease 
processes. 6-8 In this small cohort we have identified a significant delay from onset of symptoms to 
definitive care.  
There are two distinct areas in which these delays occurred. These are the pre-health system domain 
and the health system domain and it appears that both of these contribute to the overall delay to 
definitive care. This is a significant finding since strategies and avenues of research to address these 
deficits may be guided accordingly. The majority of patients in our series did not make contact with the 
healthcare system until long after the onset of oesophageal symptoms. Seeking medical attention is 
influenced by a multitude of factors, such as educational levels, awareness, inadequate infrastructure, 
endemic poverty, gender inequalities and cultural factors8. Factors that deter health-seeking behaviour 
are collectively referred to as barriers to care and have been divided into cultural (acceptability), 
Investigation % of Patients Average time to obtain 
Barium Swallow 18.5  2 mnths 
Histology 54.8 1.5 mnths 
CT scan 9.7 2.9 mnths 
Oncology Clinic 
Review 
24.7 4.4 mnths 
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financial (affordability) and structural (accessibility) issues and all of these barriers have been 
demonstrated in our study. 
Our data suggests that rural patients tolerate dysphagia and unduly ignore its significance. Loss of 
weight was far more likely to precipitate health-seeking behaviour than dysphagia with only 17 % 
presenting with dysphagia. This is a patient factor and should inform educational programs aimed at 
raising awareness around oesophageal cancer. Another source of delay which has been documented in 
similar work from our institution on delays in acute appendicitis is the need to attend a traditional 
healer first. This once again raises a potential point of intervention and it may well be possible to 
develop targeted educational initiatives for traditional healers to teach them about so-called alarm 
symptoms. This simple strategy to redirect these patients into mainstream healthcare may prove 
invaluable. The lack of funds and the long distances cited by our patients are termed barriers to health 
and reflect structural inequalities in the society.  As such these are difficult for clinicians to address.   
Of concern are the delays within the health system and this reflects lack of formal algorithms for the 
investigation of oesophageal symptoms. The long timeline is even more shocking when one compares it 
to similar studies done in other parts of the world. Table 3 compares our series with one each from India 
and Japan. The glaring difference is evident.  
 Our series INDIA 2010 
6 JAPAN 2008 7 
First 
Presentation 
5  1.2 
To diagnosis 2  1.4 
Definitive Mx 1  0.25 
OVERALL 7 3.7  2.1 
Table 3 : Comparison to other parts of the world (in months) 
 
The haphazard management approach shown in our series for investigating oesophageal symptoms is 
problematic. In addition the delays associated with each individual investigation contribute to the long 
delay to definitive treatment. It would seem that clinicians too require a raised awareness on alarm 
symptoms and the need to expedite referral and diagnosis.  A multi-disciplinary team is vital to facilitate 
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a standardized efficient approach to the management of oesophageal cancer. An enhanced investigative 
pathway could be developed in conjunction with radiology, oncology and surgery and this may well 
reduce the health care associated delays. 
Conclusion 
Patients with oesophageal cancer experience significant delays between the onset of symptoms and 
definitive surgical treatment. The reasons for this situation are multifactorial and include barriers to 
healthcare, delays in assessment, and logistical problems with healthcare resources. Understanding 
these reasons may help in developing targeted quality improvement interventions. Interventions need 
to be directed at pre-hospital delays and delays within the health system. To this end, educational 
programs around oesophageal alarm symptoms are necessary and multi-disciplinary algorithms need to 
be formalized as a matter of urgency. Only by fostering awareness amongst patients and clinicians and 
encouraging earlier presentation can we hope to impact favourably on outcomes. 
REFERENCES 
1. Kong V, Aldous C, Clarke DL . Understanding the reasons for delay to definitive surgical care of 
patients with acute appendicitis in rural South Africa S Afr J Surg 2014;52(1):2-5.  
2. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012;62:10-29. 
3.  Dubecz A, Gall I, Solymosi N, et al. Temporal trends in long-term survival and cure rates in 
esophageal cancer: a SEER database analysis. J Thorac Oncol 2012;7:443-7. 
4. Berry MF. Esophageal cancer: staging system and guidelines for staging and treatment. J Thorac 
Dis. 2014 May;6 Suppl 3:S289-97. 
5. Globocan 2012, WHO International Agency for Research on Cancer  (www.globocan.iarc.fr) 
6. Subasinghe N , Sindhia J. Delay in diagnosis of oesophageal cancer - Experience of a Single Unit 
from a Developing Country Indian J Clinical Oncology 2010;47:151-5 
7. Wang Jiaho, Lin Fung et al The symptom to treatment delay in cancer of oesophagus  and stage  at 
time of treatment Japan J Clinical Oncology 2008:38(2) 87-91 
8. Ahmed SM, Adams AM, Chowdhury M, et al. Gender, socioeconomic development and health-
seeking behaviour in Bangladesh. Soc Sci Med 2000;51(3):361-371. 
14 
 
Chapter 3 : Placement of SEMS for oesophageal cancer without fluoroscopy : A 
description of the technique and overview of its safety and efficacy 
Following on from Chapter 2, we see the high number of patients requiring palliation for advanced 
oesophageal cancer in a resource constrained setting. The technique of utilizing endoscopy alone at our 
institution was borne out of a need to offer timely palliation, in an environment where fluoroscopy was 
a scarce resource. 
The following paper focusses on inserting self-expanding metal stents as palliation for dysphagia in 
oesophageal cancer without the use of fluoroscopy. It provides a detailed description of the technique, 
as well as a five year overview of its usage at our hospital, showing it to be a safe and reproducible 















Chapter 4 : Comparing the routine use of fluoroscopy for stent insertion with 
the endoscopy alone technique : Financial and other implications 
 
We had set out to document our experience with the pure endoscopic approach of SEMS insertion for 
palliation in oesophageal cancer. 
Chapter 3 showed it to be a safe and effective technique and certainly on par with the routine use of 
fluoroscopy.Our next thought was thus : we have shown our technique to be equivalent, can we show it 
to have advantages over the standard technique? 
The following paper explored this question with specific focus on costs involved, time taken to perform 
each procedure as well as radiation exposure.In a country where healthcare and cost-cutting go hand-in-























Chapter 5: General Discussion  
 
Conclusion and Recommendations 
This research project was undertaken to address two major issues involving oesophageal cancer. One 
was palliation in a resource-constrained environment, looking specifically at self-expanding metal stent 
(SEMS) insertion. The other was to investigate the deficiencies in the diagnosis and management of this 
disease, with focus on delays. 
It can be concluded that there are statistically significant delays in the diagnosis and management of 
oesophageal cancer. Points of delay can be defined as being both pre-hospital as well as within the 
hospital system itself. These various points of delay may form the key in implementing programs to 
effect change in health-seeking behaviour. 
Our data suggests that rural patients ignore the significance of dysphagia as a symptom.  This is an 
important patient factor that could be influenced by educational programs aimed at raising awareness 
around oesophageal cancer. Another delay is the need to attend a traditional healer first. This once 
again raises a potential point of intervention. Educational initiatives for traditional healers have been 
proposed for various chronic health conditions like HIV and TB. Perhaps extending these initiatives to 
include alarm symptoms like dysphagia may redirect patients sooner into mainstream healthcare. The 
lack of money and the long distances to access healthcare reflect structural inequalities.  As such these 
are difficult for clinicians to address. Documenting them and citing them as legitimate reasons for failure 
to implement timely treatment is however still important, and it can only be hoped that those in a 
position to implement change can reflect upon these challenges. 
Delays noted within the health system are concerning.  This reflects lack of formal algorithms and multi-
disciplinary team for the investigation and management of oesophageal symptoms.  Since the 
commencement of this study, a formal algorithm has been implemented at Greys hospital for referral 
and management of oesophageal symptoms. A multidisciplinary team approach is also currently in 
place, but it is too soon to evaluate the impact of these measures. These may well provide the basis of a 
follow-up study to assess any positive impact.   
The other aspects of the study focussed on the use of SEMS for palliation of dysphagia in inoperable 
oesophageal cancer. In most institutions this procedure was performed under fluoroscopy, a resource 
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that was not readily available at our institution. To obviate the delays that this meant for our patients, 
we used a direct-vision approach which did not require fluoroscopy.  
 Our experience with this alternative technique showed it to be as safe and effective as the standard 
fluoroscopy technique. In addition, our comparative data showed it to be a viable option with respect to 
cost and time-saved. In a resource-limited setting with a high volume of advanced oesophageal cancer, 
time and cost are significant variables. Radiation exposure is also coming to the fore nowadays as an 
important occupational safety hazard. Our publication showed that our pure endoscopic technique of 
SEMS insertion is more cost and time-efficient compared to the routine use of fluoroscopy. It also has 
the additional benefit of sparing the health care worker from unnecessary radiation exposure. 
 The findings of this study add further validity to the pure endoscopic technique of SEMS placement and 
may pave the way for this procedure to be performed at many regional centres and not be restricted to 










Appendix 1: The Study Protocol 
 
Type of study : Clinical, Observational – Descriptive 
Title :  
An alternative technique for the placement of self-expanding metal stents(SEMS) for oesophageal 
cancer in a resource-limited setting – Description and cost-comparison 
Aim :  
To evaluate the safety, efficacy and cost-effectiveness of utilising a pure endoscopic technique of SEMS 
placement for the palliation of oesophageal cancer at a tertiary hospital in South Africa. 
Specific Objectives: 
1.  To provide a detailed description of an alternative technique of stent placement which utilises only 
endoscopy, as opposed to routine use of fluoroscopic guidance. To also assess safety and efficacy of this 
technique by retrospectively reviewing its usage at the GI Unit at Greys hospital, Pmb over a 5 year 
period. 
 
2. To assess the effectiveness of our SEMS placement technique with respect to relief of malignant 
dysphagia and also assess immediate and short-term complications, by performing a prospective audit 
at Greys hospital. The audit will analyse data from a 2-hour and 1-week follow-up. 
 
 
3. To compare the cost-effectiveness of using a pure endoscopic technique of SEMS insertion vs 
traditional route of SEMS insertion under routine fluoroscopy. The former technique is employed at 






Background and Literature 
SEMS is widely used for palliation of dysphagia in those patients with inoperable oesophageal cancer. In 
most institutions (locally and worldwide), it is performed under fluoroscopic guidance. At Greys hospital 
in Pmb, fluoroscopy is a resource under great demand.  Our limited access means long delays before 
patients can be stented. We have therefore been using a direct-vision approach which does not require 
fluoroscopy. This study was undertaken to document our peri-procedural experience with this pure 
endoscopic technique.(NB. There is, as yet, no published South African series utilising this approach)  
This study will be a retrospective analysis of patients stented at the GI unit at Greys hospital over a 
period of 5 years(2007 – 2011). Data will be analysed from completed procedure forms and will include 
demographics, tumour length, presence of fistulae, stent size and complications. It will include a 
description of our pure endoscopic technique and will draw comparisons to other large studies using 
similar and alternate techniques.  
A prospective arm of this study will formally evaluate our technique wrt dysphagia relief and 
complication rates. This audit will analyse data from a two-hour evaluation post-procedure, assessing 
clinical variables for evidence of immediate complications. The audit will also evaluate outcomes at a 1-
week telephonic follow-up. Pain, dysphagia scores and haematemesis will be among the variables 
analysed. 
In a busy state hospital with a limited budget, cost is unfortunately always a factor. Institutional data 
from Greys hospital shows a high burden of inoperable oesophageal cancer for which the treatment is 
palliation of the dysphagia. This can be achieved by the insertion of SEMS. As described in objective 1, 
this is performed under direct vision in our unit while SEMS insertion at IALCH in Durban is performed 
under fluoroscopic guidance. This study will provide a cost analysis of both techniques. Costing analysis 
will be extrapolated from a recent model described by Allorto NL and Clarke DL ( see reference 1 below). 
Individual cost drivers will include cost of endoscopy(ies), cost of stents; use of fluoroscopy unit; cost of 
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Appendix 3: Data collection tools  
 
 
Data Capture 1 – Greys SEMS (Retrospective) 
 
 
FIRST NAME  
SURNAME  
DATE OF BIRTH  




SITE OF LESION (cm)  
LENGTH OF LESION (cm)  
REASON FOR STENT  
STENT SIZE  
DILATATION PERFORMED  






Data Capture 2 – SEMS Cost Comparison 
 
 
Hospital :  Greys / IALCH 
Stent No.: _______________ 
Staff present :  Doctor _______________ 
                            Nurse________________ 
                            Radiographer__________ 
 
Time commenced : __________________ 
Time completed : ___________________ 
Drugs used : ________________________________________ 
                       ________________________________________ 
Equipment used : Guidewire ______________________ 
                                Stent __________________________ 
                               Scope___________________________ 
                               Dilator__________________________ 
                              Other____________________________ 
Contrast used : Yes / No 
 Volume : _______________ 
Complications : Yes / No __________________________________________________ 
                                            __________________________________________________ 





CA OES INTERVIEW FORM 
NAME         :   _____________________________________________ 
HOSP NO    :  _____________________________________________ 
ONC NO      :  _____________________________________________ 
SEX              :  _____________________________________________ 
AGE             :  _____________________________________________ 
REGION      :  _____________________________________________ 
 
FIRST SYMPTOM – WHEN  :  _________________________________ 
                                  WHAT  :  _________________________________ 
 
FIRST CONTACT WITH HEALTH CARE – WHEN         :  _________________ 
                                                                     WHERE        :  _________________ 
                                                                     SYMPTOM  :  _________________ 
___________________________________________________________ 
 
REASON FOR DELAY (if any) 
- Money 
- Distance 
- Traditional healer first 
- Other     ___________________________________________________ 
- __________________________________________________________ 
- __________________________________________________________ 
- __________________________________________________________ 
 
